[Tissue distribution of PEGylated puerarin in acute myocardial ischemia mode rats]. 2014

Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China.

The aim of this study is to explore the tissue distribution of PEGylated puerarin in acute myocardial ischemia model rats. Healthy male SD rats were randomly divided into two groups (30 each). Both were given PEGylated puerarin at a dose of 488 mg x kg(-1). After 5 min of medication, one group was normal rats, another group with acute myocardial ischemia was established by peritoneal injection of 50 mg x kg(-1) isoprenaline. After administration, the animals were executed at 30, 60, 90, 120, 150 and 180 min, then heart, liver, spleen, lung, kidney were extracted. The content of puerarin in organ tissue was determined by HPLC. The results showed that the AUC of tissue distribution of PEGylated puerarin in normal rats was liver > kidney > heart ≈ spleen > lung > brain. While the AUC of tissue distribution of PEGylated puerarin in acute myocardial ischemia model rats was liver ≈ heart > kidney > lung ≈ spleen > brain. AUC(heart) of PEGylated puerarin in acute myocardial ischemia model rats was 1.7 times than that of the normal rats, and there was significant difference (P < 0.05). Thus, PEGylated puerarin had a good heart-targeting property in early myocardial infarction area, drugs could accumulate in the ischemic myocardium. It provided important information for further study and clinic use of PEGylated puerarin.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
April 2006, Drug development and industrial pharmacy,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
December 1997, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
May 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
February 2019, Journal of pharmaceutical and biomedical analysis,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
January 2015, International journal of nanomedicine,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
December 2015, Burns : journal of the International Society for Burn Injuries,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
November 2016, Drug delivery,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
April 2016, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
June 2017, Molecules (Basel, Switzerland),
Chun-Fang Xia, and Zu-Guang Ye, and Xiang-Ning Zhou, and Tian-Tian Tang, and Ling-Jun Wen, and Xin-Yi Liu
January 2020, PloS one,
Copied contents to your clipboard!